Literature DB >> 1297449

Population studies of INV(9) chromosomes in 4,300 Japanese: incidence, sex difference and clinical significance.

K Yamada1.   

Abstract

Population incidence of a chromosome 9 with an inversion of qh, inv(9), was surveyed using C-banding in a total of 4,367 Japanese which consisted of five patient groups and a normal control group. The inv(9) incidence was 1.65% in the normal control group (n = 1,513) and 1.52% in the Down syndrome patient group (n = 1,246). The incidence of female carriers was 1.7 times higher than that of male carriers in the above two groups. The sex difference was significant (p < 0.05). Moreover, the incidence in the 47,XXY male group (n = 277) was slightly higher than female carrier incidences. The excess of carriers about 2 times was observed in the habitual abortion couple group (n = 694) and the spontaneous abortus group (n = 181), both having normal karyotypes. The present data probably indicate the existence of a genetic effect of inv(9) on human reproductive performance, while they could not explain the sex difference found in inv(9) carriers. Our speculation for the sex difference has been presented.

Entities:  

Mesh:

Year:  1992        PMID: 1297449     DOI: 10.1007/BF01883320

Source DB:  PubMed          Journal:  Jpn J Hum Genet        ISSN: 0916-8478


  12 in total

1.  Acquired pericentric inversion of chromosome 9 in essential thrombocythemia.

Authors:  T S Wan; S K Ma; L C Chan
Journal:  Hum Genet       Date:  2000-06       Impact factor: 4.132

2.  Chromosomal alterations and male infertility.

Authors:  A Antonelli; L Gandini; P Petrinelli; L Marcucci; R Elli; F Lombardo; F Dondero; A Lenzi
Journal:  J Endocrinol Invest       Date:  2000-11       Impact factor: 4.256

3.  Behavioral and developmental characteristics of children with inversion of chromosome 9 in Korea: a preliminary study.

Authors:  Jae-won Kim; Jun-young Lee; Jun-won Hwang; Kang-E Michael Hong
Journal:  Child Psychiatry Hum Dev       Date:  2005

4.  Chromosomal abnormalities in couples with recurrent spontaneous miscarriage: a 21-year retrospective study, a report of a novel insertion, and a literature review.

Authors:  Zouhair Elkarhat; Zineb Kindil; Latifa Zarouf; Lunda Razoki; Jamila Aboulfaraj; Chadli Elbakay; Sanaa Nassereddine; Boubker Nasser; Abdelhamid Barakat; Hassan Rouba
Journal:  J Assist Reprod Genet       Date:  2018-11-23       Impact factor: 3.412

5.  Successful all-trans retinoic acid treatment of acute promyelocytic leukemia in a patient with NPM/RAR fusion.

Authors:  Kiyoshi Okazuka; Masayoshi Masuko; Yoshinobu Seki; Hitomi Hama; Noriyuki Honma; Tatsuo Furukawa; Ken Toba; Kenji Kishi; Yoshifusa Aizawa
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

6.  Pattern of chromosomal aberrations in patients from north East iran.

Authors:  Saeedeh Ghazaey; Farzaneh Mirzaei; Mitra Ahadian; Fatemeh Keifi; Tootian Semiramis; Mohammad Reza Abbaszadegan
Journal:  Cell J       Date:  2013-08-24       Impact factor: 2.479

7.  De novo pericentric inversion of chromosome 9 in congenital anomaly.

Authors:  Seon-Yong Jeong; Bo-Young Kim; Jae Eun Yu
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 2.759

8.  The analysis of chromosomal abnormalities in patients with recurrent pregnancy loss, focusing on the prognosis of patients with inversion of chromosome (9).

Authors:  Taro Nonaka; Makiko Takahashi; Chika Nonaka; Takayuki Enomoto; Koichi Takakuwa
Journal:  Reprod Med Biol       Date:  2019-06-24

Review 9.  The reproductive outcome of an infertile man with AZFc microdeletions, via intracytoplasmic sperm injection in a high-risk pregnancy: Case report and literature review.

Authors:  Cong Hu; Xiangyin Liu; Linlin Li; Xiaonan Hu; Haibo Zhu; Dongfeng Geng; Ruizhi Liu; Ruixue Wang
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

10.  Pericentric inversion of chromosome 9 causing infertility and subsequent successful in vitro fertilization.

Authors:  Arun Muthuvel; Manipriya Ravindran; Aravind Chander; Chandralekha Subbian
Journal:  Niger Med J       Date:  2016 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.